Advertisement
Screener

10x Genomics, Inc. (TXG) Operating Lease Right-of-Use Assets

2.8 / 5 stars · 68/120 Roast Me

10x Genomics, Inc. Operating Lease Right-of-Use Assets

10x Genomics, Inc. (TXG) had Operating Lease Right-of-Use Assets of $56.69 million as of 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Balance Sheet › Assets › Assets, Noncurrent

us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-07

  • 2026-06-30: Operating Lease, Right-of-Use Asset $56.69M.
  • 2026-03-31: Operating Lease, Right-of-Use Asset $58.39M.
  • 2025-12-31: Operating Lease, Right-of-Use Asset $60.45M.
  • 2025-09-30: Operating Lease, Right-of-Use Asset $63.65M.
Period endOperating Lease, Right-of-Use AssetOperating Lease, Right-of-Use Asset as first filed
2026-06-30$56.69M
10-Q · filed 2026-08-07
2026-03-31$58.39M
10-Q · filed 2026-05-08
2025-12-31$60.45M
10-Q · filed 2026-08-07
2025-09-30$63.65M
10-Q · filed 2025-11-07
2025-06-30$62.70M
10-Q · filed 2025-08-08
2025-03-31$55.58M
10-Q · filed 2025-05-09
2024-12-31$57.29M
10-K · filed 2026-02-13
2024-09-30$59.58M
10-Q · filed 2024-10-29
2024-06-30$60.87M
10-Q · filed 2024-08-08
2024-03-31$62.85M
10-Q · filed 2024-04-30
2023-12-31$65.36M
10-K · filed 2025-02-13
2023-09-30$69.19M
10-Q · filed 2023-11-03
2023-06-30$71.05M
10-Q · filed 2023-08-04
2023-03-31$74.74M
10-Q · filed 2023-05-04
2022-12-31$69.88M
10-K · filed 2024-02-15
2022-09-30$71.09M
10-Q · filed 2022-11-03
2022-06-30$73.42M
10-Q · filed 2022-08-09
2022-03-31$75.68M
10-Q · filed 2022-05-05
2021-12-31$60.92M
10-K · filed 2023-02-16
2021-09-30$60.72M
10-Q · filed 2021-11-05
2021-06-30$54.13M
10-Q · filed 2021-08-06
2021-03-31$56.35M
10-Q · filed 2021-05-07
2020-12-31$46.98M
10-K · filed 2022-02-18
2020-09-30$45.38M
10-Q · filed 2020-11-12
2020-06-30$43.14M
10-Q · filed 2020-08-12
2020-03-31$44.05M
10-Q · filed 2020-05-12
2020-01-01$38.01M
10-K · filed 2021-02-26
$38.00M
10-Q · filed 2020-05-12
2019-12-31$0.00
10-Q · filed 2020-05-12